Janus Henderson Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $161M | Buy |
|
|||||
|
2025
Q2 | $98.1M | Sell |
|
|||||
|
2025
Q1 | $119M | Buy |
|
|||||
|
2024
Q4 | $143M | Buy |
|
|||||
|
2024
Q3 | $124M | Sell |
|
|||||
|
2024
Q2 | $110M | Buy |
|
|||||
|
2024
Q1 | $92.5M | Buy |
|
|||||
|
2023
Q4 | $19.3M | Sell |
|
|||||
|
2023
Q3 | $17.5M | Buy |
|
|||||
|
2023
Q2 | $8.48M | Buy |
|
|||||
|
2023
Q1 | $6.69M | Buy |
|
|||||
|
2022
Q4 | $7.43M | Buy |
|
|||||
|
2022
Q3 | $7.46M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $7.23M | Buy |
|
|||||
|
2019
Q4 | $12.3M | Sell |
|
|||||
|
2019
Q3 | $7.47M | Sell |
|
|||||
|
2019
Q2 | $12.5M | Buy |
|
|||||
|
2019
Q1 | $11.1M | Sell |
|
|||||
|
2018
Q4 | $15.9M | Buy |
|
|||||
|
2018
Q3 | $15M | Buy |
|